Qiagen (QGEN) said late Monday it has agreed to acquire Genoox for $70 million in cash plus possible milestone payments of up to $10 million.
Qiagen said the acquisition of the biotech software company is expected to add about $5 million to 2025 sales while having a neutral impact on adjusted EPS.
Genoox provides AI-powered software that allows labs to process genetic tests, the company said.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。